
Leighton Elliott
Physician · Ohiohealth
Credentials: · · · · · · ·
History
Research
RNA aggregates harness the danger response for potent cancer immunotherapy
Cell · 2024 · 121 citations
Nature Biomedical Engineering · 2025 · 27 citations
Vaccines: a promising therapy for myelodysplastic syndrome
Review · Journal of Hematology & Oncology · 2024 · 8 citations

6 papers

4 papers

4 papers

4 papers

3 papers

3 papers · 3 as a resident
- SQ
Sadeem Qdaisat
3 papers

3 papers
Clinical trials
- 2026–2027
Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)
Principal investigator · Not yet recruiting · Phase 2
University of Florida
- 2026–2027
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Principal investigator · Suspended · Phase 1
University of Florida
- 2021–2027
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Principal investigator · Recruiting · Phase 1, Phase 2
University of Florida
- 2024–2032
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)



